07:24:12 EDT Sun 16 Jun 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Chemesis International Inc
Symbol C : CSI
Shares Issued 77,854,161
Close 2019-06-12 C$ 1.59
Recent Sedar Documents

Chemesis starts commercialization of QuickStrip

2019-06-13 06:39 ET - News Release

Also News Release (C-DOSE) Rapid Dose Therapeutics Corp

Mr. Edgar Montero of Chemesis reports

CHEMESIS INTERNATIONAL INC. BEGINS COMMERCIALIZATION OF QUICKSTRIP ORAL THIN STRIPS

Chemesis International Inc. has begun commercialization of Rapid Dose Therapeutics Corp.'s QuickStrip oral thin strips. The company will deliver CBD-infused (cannabidiol) strips across the United States as well as THC- (tetrahydrocannabinol) and CBD-infused strips in Puerto Rico.

The Natural Ventures facility houses the infrastructure required to manufacture, package and distribute QuickStrip oral thin strips. Chemesis will distribute QuickStrip through subsidiary Natural Ventures' distribution network and existing relationships on the island.

As the company continues to expand its manufacturing, Chemesis will look to add additional infrastructure for its QuickStrip oral thin strips in California. In anticipation of federally changing CBD regulations, Chemesis has begun signing distribution agreements in the mainland United States for CBD-infused QuickStrip products to ensure the company maintains a first-mover advantage by forming distribution channels and partnerships that will gain market share. The proprietary drug-delivery technology is infused with CBD, THC and other cannabinoids.

The Rapid Dose Therapeutics QuickStrip delivery system is a true sublingual delivery device for THC, CBD and other cannabinoids. Furthermore, QuickStrip is conducting controlled trials to further demonstrate QuickStrip effectiveness and consistent onset. Chemesis believes this technology is at the forefront of sublingual delivery systems and will expand its efforts to bring it to market.

"We believe our partnership with Rapid Dose Therapeutics in Puerto Rico will bring an incredible amount of value to the company," said chief executive officer of Chemesis, Edgar Montero. "The innovative delivery system that is Quick, Convenient, Precise and Discreet will give consumers the ability to quickly absorb an accurate dose of THC or CBD. The company believes that QuickStrip will build significant market share as an effective method of sublingually administering cannabinoids."

About Chemesis International Inc.

Chemesis International is a vertically integrated U.S. multistate operator with international operations in Puerto Rico and Colombia. The company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new markets and is committed to differentiate itself by deploying resources in markets with major opportunities. The company operates a portfolio of brands which cater to a wide community of cannabis consumers, with focus on quality and consistency.

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.